Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Children's cancers, Liver cancer
Closed
Phase 3
The trial is looking at the treatment for 2 types of liver cancer called hepatoblastoma (HB) and hepatocellular carcinoma (HCC).
Recruitment start: 25 August 2017
Recruitment end: 1 December 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Madhumita Dandapani
The Little Princes Trust
University of Birmingham
2016-002828-85, ISRCTN17869351, Liver cancer clinical trial, research, study, Cancer Research UK Clinical Trials Unit at the University of Birmingham, European Union Research, Innovation Programme Horizon 2020, Professor Bruce Morland, Cisplatin, Doxorubicin, Carboplatin, Fluorouracil, Vincristine, Etoposide, Irinotecan, Sorafenib, Gemcitabine, Oxaliplatin, PHITT, Treatment, Children, Hepatoblastoma carcinoma, Hepatocellular carcinoma, HB, HCC, PLADO, GEMOX, SIOPEL-3HR, C5VD, Cisplatin CDDP-M
Last reviewed: 15 June 2025
CRUK internal database number: 15024
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
